These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37094689)

  • 1. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.
    Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ
    Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.
    Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
    Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M
    Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers.
    van Dieren JM; Kodach LL; den Hartog P; van der Kolk LE; Sikorska K; van Velthuysen MF; van Sandick JW; Koemans WJ; Snaebjornsson P; Cats A
    Endoscopy; 2020 Oct; 52(10):839-846. PubMed ID: 32408363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random biopsies in patients harboring a CDH1 mutation: time to change the approach?
    Castro R; Lobo J; Pita I; Videira F; Pedro-Afonso L; Dinis-Ribeiro M; Brandão C
    Rev Esp Enferm Dig; 2020 May; 112(5):367-372. PubMed ID: 32338015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.
    Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.
    Asif B; Sarvestani AL; Gamble LA; Samaranayake SG; Famiglietti AL; Fasaye GA; Quezado M; Miettinen M; Korman L; Koh C; Heller T; Davis JL
    Lancet Oncol; 2023 Apr; 24(4):383-391. PubMed ID: 36990610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance.
    Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M
    J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1.
    Mejia Perez LK; O'Malley M; Chatterjee A; Lyu R; Yang Q; Cruise MW; LaGuardia L; Liska D; Macaron C; Walsh RM; Burke CA
    Fam Cancer; 2024 Nov; 23(4):617-626. PubMed ID: 39261344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
    Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
    Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
    Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
    JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies.
    Fujita H; Lennerz JK; Chung DC; Patel D; Deshpande V; Yoon SS; Lauwers GY
    Am J Surg Pathol; 2012 Nov; 36(11):1709-17. PubMed ID: 23073328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1.
    Yamada M; Fukagawa T; Nakajima T; Asada K; Sekine S; Yamashita S; Okochi-Takada E; Taniguchi H; Kushima R; Oda I; Saito Y; Ushijima T; Katai H
    Gastric Cancer; 2014 Oct; 17(4):750-6. PubMed ID: 24037103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
    van der Post RS; van Dieren J; Grelack A; Hoogerbrugge N; van der Kolk LE; Snaebjornsson P; Lansdorp-Vogelaar I; van Krieken JH; Bisseling TM; Cats A
    Gastrointest Endosc; 2018 Feb; 87(2):397-404.e2. PubMed ID: 28455161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.